Direct Adjustment No. 587/2026 - Acquisition of the medication Eplontersen 45 mg/0.8 ml Injection Solution 0.8 ml SC - 517706

World Biggest Tenders Source

This tender with title Direct Adjustment No. 587/2026 - Acquisition of the medication Eplontersen 45 mg/0.8 ml Injection Solution 0.8 ml SC - 517706 -- Contract Value: 2 738 503,50 EUR has been published on Bidding Source portal dated 30 Jul 2026 for the country of Portugal. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

Contract Value: 2 738 503,50 EUR

General Information

Portugal

Tender Title :

Direct Adjustment No. 587/2026 - Acquisition of the medication Eplontersen 45 mg/0.8 ml Injection Solution 0.8 ml SC - 517706
Contract Value: 2 738 503,50 EUR

Tender Type :

Contract Award

Reference No. :

517706

Country :

Portugal

Publish Date :

30 Jul 2026

Notice Language :

English

Tender Categories (CPVs) :

Pharmaceutical products

Full Tender Details :

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

Awarded - 41012526 Nonacog beta pegol 1000 IU powder for IV injection and Nonacog Beta Pegol 2000 IU powder for IV injection - 546733 -- Contract Value: 770 295,80 EUR Portugal Awarded - 41022526 - Acquisition of IVACAFTOR 75 MG + TEZACAFTOR 50 MG + ELEXACAFTOR 100 MG Gran Saq - 547437 -- Contract Value: 123 867,81 EUR Portugal Awarded - Centralized aggregation of medicines for the year 2026 - process no. 2026/0339: Acquisition of the medicine: Ivafactor [150 MG; CAPSULES/COMPRESSORS] - 529226 -- Contract Value: 1 358 496,62 EUR Portugal Awarded - Public Bidding Notice No. 578/2026 for the acquisition of the medication Efmoroctocog alfa 333 IU/ml Powder for injection, IV vial. - 530932 -- Contract Value: 902 500,00 EUR Portugal Awarded - 2023/0491 - OCRELIZUMAB [300 MG/ 10 ML SOL INJ FRS] - 520670 Portugal Awarded - 2023/0491 - DARATUMUMAB [120 MG/ ML 15 ML SOL INJ FRS] - 521082 Portugal Awarded - 2024/0900 - LAMIVUDINE + DOLUTEGRAVIR [300 MG + 50 MG TABLETS] - 520479 Portugal Awarded - 2023/0491 - PEMBROLIZUMAB [25 MG/ ML 4 ML SOL INJ FRS] - 522490 Portugal Awarded - 2024/0900 - BICTEGRAVIR + EMTRICITABINA + TENOFOVIR ALAFENAMIDA [50 + 200 + 25 MG CAP/ COMP] - 521471 Portugal Awarded - 2025/1746 - EMICIZUMAB [150 MG/ML 0,7 ML SOL INJ FRS] - 521406 Portugal

Direct Adjustment No. 587/2026 - Acquisition of the medication Eplontersen 45 mg/0.8 ml Injection Solution 0.8 ml SC - 517706

Contract Value: 2 738 503,50 EUR

General Information

Portugal

Similar Tenders

Pharmaceutical products Tenders

Portugal Tenders

Europe Tenders

Tenders

info@biddingsource.com